fda semaglutide obesity approves first-ever oral GLP-1RA for and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults Wegovy FDA Approval: CV Risk

The Mediterranean diet, rich in polyphenols (e.g., olive oil, nuts, berries), reduces lipid peroxidation (MDA) and enhances antioxidant enzymes (SOD, GPx) in diabetic patients (Ruiz-Pozo et al., 2024)

If your pharmacy includes B12 at a lower concentration, you may want to supplement with additional oral or sublingual B12 between injections, especially at lower semaglutide doses where injection volume (and therefore B12 delivery) is minimal

Abdominal Fat Burn: Helps reduce localized fat in the abdomen

GLP-1 agonists, on the other hand, have been demonstrated in further trials to cause significant weight loss in a relatively short amount of time

Main Factors Driving Growth in the GLP-1 Agonist Market : There are a number of important factors that are helping the GLP-1 Agonist Market grow and change: 1